Status:
COMPLETED
the Prevalence of Oral Manifestation in Patients With SARS-CoV2 Infection
Lead Sponsor:
Fayoum University
Collaborating Sponsors:
Ministry of Health and Population, Egypt
Conditions:
SARS-CoV2 Infection
Eligibility:
All Genders
18-60 years
Brief Summary
The SARS-Cov2 virus was identified in china at the end of 2019 and spread worldwide causing a global pandemic. Current research showed that SARS-Cov2 virus invades human cells via the receptor angiote...
Detailed Description
The oral cavity is particularly susceptible to viral infection with several viruses such as herpes simplex virus, cytomegalovirus and Zika virus because of its structures, especially salivary glands a...
Eligibility Criteria
Inclusion
- A diagnosis of SARS-CoV2 with PCR.
- Age range from 18-60 years old
- Hospital admission not more than 10 days
Exclusion
- Pregnancy or contraceptive pills
- Lactation
- Any auto-immune disease that could affect the oral mucosa
- On any neoplastic therapy.
- Uncontrolled diabetes.
Key Trial Info
Start Date :
May 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2021
Estimated Enrollment :
385 Patients enrolled
Trial Details
Trial ID
NCT04893694
Start Date
May 20 2021
End Date
July 15 2021
Last Update
August 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry
Al Fayyum, Egypt, 63514